Cargando…
Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality
BACKGROUND: Identification of lifestyle modifiable metabolic pathways related to cardiometabolic disease risk is essential for improvement of primary prevention in susceptible individuals. It was recently shown that plasma dimethylguanidino valerate (DMGV) levels are associated with incident type 2...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806048/ https://www.ncbi.nlm.nih.gov/pubmed/31533499 http://dx.doi.org/10.1161/JAHA.119.012846 |
_version_ | 1783461538121646080 |
---|---|
author | Ottosson, Filip Ericson, Ulrika Almgren, Peter Smith, Einar Brunkwall, Louise Hellstrand, Sophie Nilsson, Peter M. Orho‐Melander, Marju Fernandez, Céline Melander, Olle |
author_facet | Ottosson, Filip Ericson, Ulrika Almgren, Peter Smith, Einar Brunkwall, Louise Hellstrand, Sophie Nilsson, Peter M. Orho‐Melander, Marju Fernandez, Céline Melander, Olle |
author_sort | Ottosson, Filip |
collection | PubMed |
description | BACKGROUND: Identification of lifestyle modifiable metabolic pathways related to cardiometabolic disease risk is essential for improvement of primary prevention in susceptible individuals. It was recently shown that plasma dimethylguanidino valerate (DMGV) levels are associated with incident type 2 diabetes mellitus. Our aims were to investigate whether plasma DMGV is related to risk of future coronary artery disease and with cardiovascular mortality and to replicate the association with type 2 diabetes mellitus and pinpoint candidate lifestyle interventions susceptible to modulate DMGV levels. METHODS AND RESULTS: Plasma DMGV levels were measured using liquid chromatography‐mass spectrometry in a total of 5768 participants from the MDC (Malmö Diet and Cancer Study—Cardiovascular Cohort), MPP (Malmö Preventive Project), and MOS (Malmö Offspring Study). Dietary intake assessment was performed in the MOS. Baseline levels of DMGV associated with incident coronary artery disease in both the MDC (hazard ratio=1.29; CI=1.16–1.43; P<0.001) and MPP (odds ratio=1.25; CI=1.08–1.44; P=2.4e‐3). In the MDC, DMGV was associated with cardiovascular mortality and incident coronary artery disease, independently of traditional risk factors. Furthermore, the association between DMGV and incident type 2 diabetes mellitus was replicated in both the MDC (hazard ratio=1.83; CI=1.63–2.05; P<0.001) and MPP (odds ratio=1.65; CI=1.38–1.98; P<0.001). Intake of sugar‐sweetened beverages was associated with increased levels of DMGV, whereas intake of vegetables and level of physical activity was associated with lower DMGV. CONCLUSIONS: We discovered novel independent associations between plasma DMGV and incident coronary artery disease and cardiovascular mortality, while replicating the previously reported association with incident type 2 diabetes mellitus. Additionally, strong associations with sugar‐sweetened beverages, vegetable intake, and physical activity suggest the potential to modify DMGV levels using lifestyle interventions. |
format | Online Article Text |
id | pubmed-6806048 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68060482019-10-28 Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality Ottosson, Filip Ericson, Ulrika Almgren, Peter Smith, Einar Brunkwall, Louise Hellstrand, Sophie Nilsson, Peter M. Orho‐Melander, Marju Fernandez, Céline Melander, Olle J Am Heart Assoc Original Research BACKGROUND: Identification of lifestyle modifiable metabolic pathways related to cardiometabolic disease risk is essential for improvement of primary prevention in susceptible individuals. It was recently shown that plasma dimethylguanidino valerate (DMGV) levels are associated with incident type 2 diabetes mellitus. Our aims were to investigate whether plasma DMGV is related to risk of future coronary artery disease and with cardiovascular mortality and to replicate the association with type 2 diabetes mellitus and pinpoint candidate lifestyle interventions susceptible to modulate DMGV levels. METHODS AND RESULTS: Plasma DMGV levels were measured using liquid chromatography‐mass spectrometry in a total of 5768 participants from the MDC (Malmö Diet and Cancer Study—Cardiovascular Cohort), MPP (Malmö Preventive Project), and MOS (Malmö Offspring Study). Dietary intake assessment was performed in the MOS. Baseline levels of DMGV associated with incident coronary artery disease in both the MDC (hazard ratio=1.29; CI=1.16–1.43; P<0.001) and MPP (odds ratio=1.25; CI=1.08–1.44; P=2.4e‐3). In the MDC, DMGV was associated with cardiovascular mortality and incident coronary artery disease, independently of traditional risk factors. Furthermore, the association between DMGV and incident type 2 diabetes mellitus was replicated in both the MDC (hazard ratio=1.83; CI=1.63–2.05; P<0.001) and MPP (odds ratio=1.65; CI=1.38–1.98; P<0.001). Intake of sugar‐sweetened beverages was associated with increased levels of DMGV, whereas intake of vegetables and level of physical activity was associated with lower DMGV. CONCLUSIONS: We discovered novel independent associations between plasma DMGV and incident coronary artery disease and cardiovascular mortality, while replicating the previously reported association with incident type 2 diabetes mellitus. Additionally, strong associations with sugar‐sweetened beverages, vegetable intake, and physical activity suggest the potential to modify DMGV levels using lifestyle interventions. John Wiley and Sons Inc. 2019-09-19 /pmc/articles/PMC6806048/ /pubmed/31533499 http://dx.doi.org/10.1161/JAHA.119.012846 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Research Ottosson, Filip Ericson, Ulrika Almgren, Peter Smith, Einar Brunkwall, Louise Hellstrand, Sophie Nilsson, Peter M. Orho‐Melander, Marju Fernandez, Céline Melander, Olle Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality |
title | Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality |
title_full | Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality |
title_fullStr | Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality |
title_full_unstemmed | Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality |
title_short | Dimethylguanidino Valerate: A Lifestyle‐Related Metabolite Associated With Future Coronary Artery Disease and Cardiovascular Mortality |
title_sort | dimethylguanidino valerate: a lifestyle‐related metabolite associated with future coronary artery disease and cardiovascular mortality |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806048/ https://www.ncbi.nlm.nih.gov/pubmed/31533499 http://dx.doi.org/10.1161/JAHA.119.012846 |
work_keys_str_mv | AT ottossonfilip dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality AT ericsonulrika dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality AT almgrenpeter dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality AT smitheinar dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality AT brunkwalllouise dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality AT hellstrandsophie dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality AT nilssonpeterm dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality AT orhomelandermarju dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality AT fernandezceline dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality AT melanderolle dimethylguanidinovaleratealifestylerelatedmetaboliteassociatedwithfuturecoronaryarterydiseaseandcardiovascularmortality |